StonvexLoading…
StonvexStonvexStonvexCore line items from DRH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.12B | $1.13B | $1.07B | $1.00B |
Operating Income | $100.71M | $49.79M | $86.95M | $112.31M |
Net Income | $101.43M | $48.05M | $86.34M | $109.33M |
EPS (Diluted) | $0.44 | $0.18 | $0.36 | $0.47 |
Total Assets | $3.00B | $3.17B | $3.24B | $3.21B |
Total Liabilities | $1.55B | $1.57B | $1.59B | $1.61B |
Cash & Equivalents | $68.08M | $81.38M | $121.59M | $67.56M |
Free Cash Flow OCF − CapEx | $162.09M | $142.82M | $151.25M | $138.58M |
Shares Outstanding | 203.70M | 207.59M | 209.63M | 209.37M |